Feud Intensifies Between ‘Hypocritical’ Planned

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
174
Feud Intensifies Between ‘Hypocritical’
Planned Parenthood and Ousted Physician President
< >

Dr.-Leana-Wen-640x480.png


The public feud between Planned Parenthood and its recently ousted physician president is intensifying as Dr. Leana Wen accuses the left-wing organization of hypocrisy and attempted intimidation.

In a letter to Planned Parenthood’s board of directors that was obtained by the New York Times, the former president and CEO accused the group of holding her health insurance and severance pay as “ransom” until she agreed to sign a confidentiality agreement.

In the letter, Wen reportedly wrote, “I have no desire to file claims against Planned Parenthood for defamation, retaliation, or discrimination,” but then added that the organization was demanding she stop speaking publicly “in exchange for my contractually-guaranteed severance and continued health insurance coverage.”

Wen referred to Planned Parenthood’s actions as “unjust” and “unethical,” said the Times.

The battle between Wen and the abortion giant comes as Planned Parenthood has been more open that abortion is its central priority.

Though, for years, the group insisted abortion was a very small part of the “healthcare” services it provided, ultimately Planned Parenthood opted not to remain in the federal Title X family planning grant program when the Trump administration decided to enforce the program’s rule that grantees of the funds not refer for or perform abortions.

The organization abandoned the program, leaving about $60 million behind in federal funding that will now be redirected to federally qualified healthcare centers that do not perform abortions.

In her letter, Wen reportedly referred to the Trump administration’s Title X rule enforcement as she accused Planned Parenthood’s board of hypocrisy.

“It is deeply hypocritical,” she wrote, that her former organization, “would attempt to enforce a gag order on its immediate past President/CEO while fighting the Trump administration’s gag rule on Title X providers.”

According to the Times, Melanie Newman, senior vice president for communications at Planned Parenthood, said Wen’s accusations are “unfortunate, saddening, and simply untrue.”

“The attorneys representing the board have made every good faith effort to amicably part from Dr. Wen, and are disappointed that they have been unable to reach a suitable resolution regarding her exit package,” she added.

Newman claims Wen received in her severance package a full additional year of salary and health benefits “under terms that are standard and consistent with her employment agreement and any reasonable executive exit package.”

Nevertheless, Wen, who expressed disappointment in a Twitter post that her letter leaked out, said, “There should be no dispute regarding the terms of my employment contract, which are clearly spelled out.”

The ousted president’s tenure at Planned Parenthood lasted less than a year. At the time Wen was hired, the organization announced her as its choice for president with much fanfare that Planned Parenthood would have its first physician president in decades. The group gave the appearance of showing interest in developing its non-abortion services.

When she was suddenly fired in July, Wen at first referred in a tweet to the reason for her ouster as “philosophical differences” with the board, but then elaborated on that reference in a three-page letter to Planned Parenthood colleagues and supporters.

She explained:

One year ago, when I came in front of the Search Committee selecting Planned Parenthood’s next President, I posed this question: Did they see Planned Parenthood as an advocacy organization first, with medical services that are necessary to strengthen its impact, or did they see Planned Parenthood as a health care organization first, with advocacy as a necessary vehicle to protect rights and access?

Wen said she believed she was coming in as Planned Parenthood president to “run a national health care organization and to advocate for the broad range of public health policies that affect our patients’ health.”

“The new Board leadership has determined that the priority of Planned Parenthood moving forward is to double down on abortion rights advocacy,” she said.

According to the Times, Wen said in her letter she believed the best way to protect Planned Parenthood from the Trump administration and states eager to restrict abortion and cut the group’s funding would be to de-emphasize its abortion services.

“However,” she reportedly wrote, “there is a vocal minority,” including many national staff and board members, “who prefer a stridently political, abortion-first philosophy.”

The struggle between Wen and the Planned Parenthood organization became palpable in January after Wen’s interview with BuzzFeed News that was published with the headline, “Planned Parenthood’s New President Wants to Focus on Nonabortion Health Care.”

Following its publication, however, Wen tweeted the headline “completely misconstrue[d] my vision for Planned Parenthood.”

The physician then made what may be the most memorable announcement of her tenure at Planned Parenthood: Abortion is “our core mission.”

After Wen’s ouster, a report at Politico indicated a former Planned Parenthood employee denied the existence of “philosophical differences” between Wen and the board. The anonymous ex-staff member described Wen as an “incompetent manager” who had done significant “damage” to the organization.

At the time of Wen’s ouster, Troy Newman, president of pro-life group Operation Rescue, said the developing feud between Wen and Planned Parenthood was providing the country with “a glimpse of the disarray and division within Planned Parenthood’s ranks.”

“What we are seeing right now is a desperate attempt to regain political power it lost when President Trump took office in 2017,” he added. “They are willing to throw anyone and everyone under the bus to get that power back.”

Currently, Planned Parenthood still receives over $500 million in taxpayer funds as reimbursements through the Medicaid program.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ballard Power Eyes Profitability and Growth by 2028

Updated Category News Views 2

Ballard's Bold Vision for the Future In the sweaty scramble of this hydrogen race, Ballard Power Systems flung their ambition squarely into the ring. Their eyes are set on Adjusted EBITDA profitability by the end of 2027 with a full-year stretch into 2028. It's not just hope they're peddling; they've got a plan, folks! Unpacking the Numbers: Revenue and Strategy...

Continue Reading
Sony's IMX742: Revolutionizing Endoscopic Imaging

Updated Category News Views 7

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Continue Reading
Brewer Foundation Shatters Records with IPPF Entries

Updated Category News Views 3

A New Milestone in Global Debate The Brewer Foundation is making waves across the debate world, claiming a groundbreaking enrollment for their 2026-27 International Public Policy Forum (IPPF). Let’s talk numbers for a moment—506 teams from a whopping 62 different countries, not to mention new entries from places like France, Mexico, Curaçao, and Russia, all eager to...

Continue Reading
Chemours Investors Face Crucial Class Action Deadline

Updated Category News Views 7

High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...

Continue Reading
Rentvine Unleashes AI Innovations in Property Management

Updated Category News Views 5

Rentvine's Leap in AI Technology Right off the bat, let's give these guys some due credit. Rentvine, located in Bonita Springs, is tearing through the property management software scene like a train on rocket fuel. They just rolled out a suite of AI tools that's shaking up the single-family rentals management industry. During NARPM National in Las Vegas, they showcased...

Continue Reading
45% of Firms Lack AI Integration Leadership

Updated Category News Views 3

Unclaimed Territory in the AI Era Mid-market businesses have leapt onto the AI bandwagon with wild enthusiasm, yet they're stumbling in the dark when it comes to making it work. The latest findings from Lever Talent, a talent evolution firm, spill the beans that about 45% of these outfits lack a designated maestro to lead the AI-human orchestra. Without a clear conductor,...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 8

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
Graybar's Integrity Shines: Forbes Honors Trust Again

Updated Category News Views 0

Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...

Continue Reading
ManpowerGroup to Feature at J.P. Morgan Conference

Updated Category News Views 5

ManpowerGroup Heads to the Big Apple ManpowerGroup's top brass are packing their bags for New York City, heading to the J.P. Morgan Ultimate Services Investor Conference. Now, this isn’t just another cookie-cutter investor meet-up. Jack McGinnis, the CFO, and Becky Frankiewicz, the President and Chief Strategy Officer, are slated to have a fireside chat on November 17,...

Continue Reading
Elanco's Strategic Shift: Jamie Preston Takes the Helm

Updated Category News Views 6

Elanco's Bold HR Transition: A New Leader Steps Up Well, here's a shake-up that might just turn a few heads in the corporate world. Elanco Animal Health, the outfit with the ticker NYSE:ELAN that many have their eyes on, is shuffling its HR deck, bringing in Jamie Preston from Eli Lilly to take charge as the new Chief People Officer. Mark November 3rd on your calendars;...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Replimune Group Faces Class Action Deadline

Updated Category News Views 103

Replimune Group, Inc. Shareholder Class Action Notification The Gross Law Firm wishes to inform investors of Replimune Group, Inc. (NASDAQ: REPL) about an important class action lawsuit that is currently in progress. This notice serves as a prompt to shareholders who purchased shares during the specified class period to engage with the firm regarding possible lead...

Continue Reading
First Commerce Bancorp Delivers Strong Performance Metrics

Updated Category News Views 125

Company Overview First Commerce Bancorp, Inc. (CMRB), parent company of First Commerce Bank, has recently announced impressive financial results for the second quarter and year-to-date periods ending June 30, 2025. This performance underscores the bank's strategic initiatives and growth trajectory in a competitive financial landscape. Financial Performance Highlights...

Continue Reading
Silo Pharma Achieves Patent Success and Stock Surge

Updated Category News Views 195

Silo Pharma Achieves New Patent Milestone Silo Pharma Inc. recently experienced a significant boost in its stock prices following an important announcement regarding its lead product, SPC-15, a treatment designed for PTSD. This surge comes on the heels of the company securing a new U.S. patent for its innovative approach to treating post-traumatic stress disorder....

Continue Reading
Discovering Willows at Brookfield: A New Luxury Townhome Community

Updated Category News Views 170

Welcome to Willows at Brookfield Willows at Brookfield, a newly unveiled luxury townhome community, is making waves in the housing market. Known for its stunning architectural designs and modern conveniences, this community is set to become a sought-after location for homebuyers. Nestled near beautiful landscapes and outdoor recreational spots, this neighborhood features...

Continue Reading
Exploring New Depths: VR Resources' Advances in Copper Exploration

Updated Category News Views 219

Innovative Geophysical Surveys Completed at Empire and Silverback Projects VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF) has achieved a significant milestone with the completion of two advanced Direct Current Induced Polarization (DCIP) geophysical surveys at their Empire and Silverback projects located in Northwestern Ontario. As these state-of-the-art surveys...

Continue Reading